Jared Robinson, PA
Family Medicine · Canton, GANPI 1407407828
Payments from drug & device makers
Across 217 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$721
- AbbVie$524
- AstraZeneca$322
- Novartis$312
- Lilly USA, LLC$247
- GSK$226
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,963100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 57 | $721 |
| AbbVie | 29 | $524 |
| AstraZeneca | 14 | $322 |
| Novartis | 12 | $312 |
| Lilly USA, LLC | 16 | $247 |
| GSK | 13 | $226 |
| Pfizer | 10 | $221 |
| Bayer | 8 | $176 |
| Medtronic | 3 | $161 |
| Boehringer Ingelheim | 6 | $128 |
| Merck | 5 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| Atricure, Inc. | 1 | $61 |
| Exact Sciences | 3 | $52 |
| Currax Pharmaceuticals LLC | 4 | $51 |
| Astellas Pharma US Inc | 2 | $48 |
| Idorsia Pharmaceuticals US Inc | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $44 |
| Amarin Pharma, Inc. | 2 | $41 |
| Boston Scientific | 1 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Amgen | 2 | $32 |
| Johnson & Johnson | 2 | $31 |
| Dynavax Technologies Corporation | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $26 |
| Saluda Medical Americas, Inc. | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| VBI Vaccine (delaware) Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
| Qiagen, LLC | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$121
- INTELLIS ADAPTIVESTIM$115
How this compares
$3,963 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluoxetine Hcl | 13 | $229 |
| Lisinopril | 20 | $225 |
| Atorvastatin Calcium | 28 | $174 |
| Pantoprazole Sodium | 13 | $164 |
| Gabapentin | 11 | $145 |
| Buspirone Hcl | 11 | $119 |
| Losartan Potassium | 19 | $102 |
| Levothyroxine Sodium | 24 | $96 |
| Amlodipine Besylate | 23 | $58 |
| Meloxicam | 11 | $50 |
| Rosuvastatin Calcium | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Canton
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.